The IOCDF is not affiliated with any of the following studies, although we ensure that all research studies listed on this page have been reviewed and approved by an Internal Review Board (IRB). We do our best to keep this list up-to-date, but please contact the research institutions directly to confirm the status of any studies you are interested in. If you are an organization interested in posting a research study below, please click here.
Want to read about more research studies? Check out Research Match and clinicaltrials.gov for additional study listings.
Are you in the United Kingdom and interested in joining a research study? Check out the Orchard OCD Registry and register to receive study alerts.
Other Ways to Make a Difference
Registering to donate brain tissue at the end of life is an act of generosity that makes a unique and lasting impact. Scientists are in need of brain tissue from both healthy people and people who had OCD or a related disorder during life. If you would like to learn more about registering to become a brain donor, please visit braindonorproject.org. Read more about OCD research made possible through brain donation by clicking here.
Research Studies: Online/Phone/Mail
Have you, your child, or a loved one ever been diagnosed with OCD or are currently experiencing OCD Symptoms?
Researchers are studying the genetics and presentation of OCD in Black or African American individuals.
You and your family could get paid up to $100 for participating in this remote study.
What's involved?
Step 1: Contact us to learn about the research study from our team and give your consent to participate on a confidential platform.
Step 2: A member of our study team will interview you (or you and your child) about your experience with OCD symptoms.
Step 3: We will mail you a saliva collection kit so you can provide a sample at home and mail it back (at no cost to you) to the study team.
To participate in BELONG, you or your child must:
- Have a prior diagnosis of OCD or a suspicion of OCD
- Identify as Black or African American or have at least one grandparent who identifies as Black or African American
- Be between the ages of 5 and 70.
Contact BELONG@mssm.edu to learn more about the BELONG study and help us address the current inequalities in genomics studies of OCD.
Do you struggle with Obsessive Compulsive Disorder? This entirely virtual study entails engaging with a digital intervention for 1-2 hours per week for 5-weeks. Individuals interested in joining the study must be 18 years or older. You will be compensated up to $80 for your participation. Please contact Arianna Carpati (acarpati@mail.yu.edu) with any questions or concerns, and fill out the link below if you are interested in being contacted to participate!
https://yeshiva.co1.qualtrics.com/jfe/form/SV_eyBlI8oT0v0G1WS
Chatbots are used by millions of folks with OCD, but therapists and doctors often don’t know how. If you are between 18-65 years old and have OCD or OCD symptoms, fill out this 15-minute survey to help improve treatment from now into the future!
on sleep and anxiety in the perinatal period! The purpose of this study is to examine the
associations between sleep disruption and anxiety from the third trimester of pregnancy
through 6 months postpartum in adults ages 18-45. The study includes completing 3
online surveys at home during the third trimester, 2 months postpartum, and 6 months
postpartum. Compensation is up to $60, including a drawing to win a $100 gift card! For
more details and information on how to apply, please visit the website in our bio
(https://sites.wustl.edu/scraplab/) or email us at scraplab@wustl.edu and ask about the
perinatal sleep study.
- You are a parent of a child between 12 and 18 years old
- Your child currently pulls their hair
- You live with your child at least 50% of the time
- English is your and your child's primary language
- The parent portion takes about 15-20 minutes
- The child portion (if applicable) also takes about 15-20 minutes
OCD treatment is hard to access for many reasons, and we want to help change that.
We're developing a free online program designed to reduce caregiver stress and help break the cycle of OCD as part of a research study.
- Access to a digital program for OCD
- No cost to you, up to $45 in compensation
- Follow-up surveys (2 & 4 weeks)
- Voluntary + Asynchronous + From your own home
- Who are we? Researchers at Boston University and the Center for OCD and Related Disorder at MGH/Harvard Medical School
- Interested? participate here: https://bostonu.qualtrics.com/
jfe/form/SV_bOPMGv71syWxApw
Learn more here: www.leafbyleaf.org/empowerocd
Share with your caregivers if you'd like them to learn more about how to best support you!
- One 60-90 minute Zoom interview that will be video-recorded.
- To protect participants’ privacy, the published study will not share any names or identifying details.
- 18 years of age or older
- have received a formal diagnosis of obsessive–compulsive disorder
- have experienced pedophilic OCD (unwanted obsessions and compulsions involving fear of harming children)
- resident of the United States
Do you have obsessive-compulsive disorder (OCD) and identify as spiritual or religious – or formerly spiritual or religious?
The Psychiatry and Behavioral Sciences Department at Baylor College of Medicine is partnering with Stick with the Ick, an inclusive spiritual community for individuals across religious/spiritual traditions navigating OCD, on an anonymous online study that we hope will help us understand how religion and positive and negative faith-based experiences might relate to symptoms of OCD. To learn more about the study, you can access the anonymous survey at https://bcmpsych.sjc1.qualtrics.com/jfe/form/SV_8CSV5XdwAxZynuS or email Kate Foshee at Katherine.foshee@bcm.edu; kate.foshee@bcm.edu.
We want to hear your voice.
In a new global initative, researchers at the Karolinska Institute in Stockholm, Sweden, want to better understand which aspects of daily life are affected most by OCD and what should be included as standard measures in OCD clinical trials.
You are welcome to participate if you are 18 years or older and you agree that we use your anonymous replies for our research. The survey will take about 5-10 minutes to complete.
Click on the link below if you want to know more:
Thank you for your contribution!
Researchers at Baylor College of Medicine are conducting a study to understand how to improve the detection and diagnosis of obsessive-compulsive disorder (OCD). We are looking for adults with OCD who are willing to speak with us about their experiences of seeking a diagnosis.
If you have been diagnosed with OCD by a licensed mental health professional (psychiatrist, psychologist, clinical social worker, or professional counselor), you may be eligible to participate in a one-time, paid research interview. Participation should take no more than 45 minutes of your time, and your responses will be kept confidential.
We can only complete this project with the help of people with OCD. In total, we are looking for 25 adult patients to speak about their experiences of diagnosis. This research is sponsored by the National Academy of Medicine and is led by Dr. Andrea Bradford, Associate Professor, and her colleagues at Baylor College of Medicine.
For more information about the study and to express interest in taking part, visit https://redcap.link/ocddx
Acceptance and Commitment Therapy Guide for Obsessive Compulsive Disorder
The USU ACT lab is seeking participants for a study examining the potential benefits of using an online self-help intervention based on acceptance and commitment therapy (ACT) to decrease the impact of OCD symptoms and analyzing the level of feasibility for adults with OCD.
Participation will involve:
- Completing an initial online assessment and an interview via Zoom
- Completing a six-module treatment website over the course of 6 weeks OR wait 10 weeks before being given access to the program
- Completing 3 assessments over the course of 10 weeks via Zoom
- We estimate that participation will take 5-6 hours total
In order to be eligible you must:
- Meet DSM-V criteria for OCD (do not need an official diagnosis before intake)
- Be over 18 years old
- Living in the United States
- Fluent in English
- Interested in receiving treatment for OCD
- Not recently (within the past 30 days) or planning to change medications
- Not currently or planning (in the next 10 weeks) to engage in therapy for OCD or anxiety
Please know that participation is voluntary, and you can withdraw at any time without penalty. You can receive up to $40 in gift cards for completing all surveys in the study. Please visit https://utahact.com/ocdstudy for more information and initial enrollment steps.
Complete our eligibility questionnaire to see if you qualify and let us know you are interested: https://usu.co1.qualtrics.com/jfe/form/SV_cMEGvxXavGSIaMK
If you're eligible based on the initial screening, you'll be invited to complete an intake interview. Please contact Keaton Soileau at Keaton.soileau@usu.edu if you have any questions or concerns.
This study is USU IRB # 14744 and the principal investigator is Dr. Michael Twohig (Michael.twohig@usu.edu).
Participants Needed! Study on Obsessions and Compulsions
You May Qualify If You
- Experience persistent, unwanted thoughts or urges (e.g., feeling like thinking something might cause it to happen).
- Feel driven to repeat behaviors or mental rituals in response to obsessions (e.g., doing rituals to prevent something bad)
- Are between the ages of 21-65
- Fluent in English language
- Reside in the USA
- Computer access with camera and reliable wi-fi
Potential Benefits
- Your participation can help us better understand and serve individuals with OCD
Participation Involves
- A one-time on-line survey (approx. 30 minutes)
- A one-time Zoom session with researchers (approx. 90 minutes)
Compensation
- Complete a one-time survey (LINK BELOW!) to enter a drawing to earn a $100 gift card
- Eligible participants will earn a $30 gift card & $50 gift card drawing entry for completion of Zoom session with researchers
For more information contact: ocdstudyaiu@outlook.com and mention "OCD study"
CLICK HERE TO PARTICIPATE! https://alliant.qualtrics.com/jfe/form/SV_3yhf72uWjagd21E
Approved by Alliant International University Institutional Review Board # IRB-AY2024-2025-358
My name is Adam Frank, MD, PhD, and I am a faculty member at the University of Southern California. I may also be a colleague of yours through Keck Medicine of USC. I am conducting a research study to understand how clinicians who provide care to individuals with Obsessive-Compulsive Disorder (OCD) feel about the use of wearable sensors, smartphone apps, and machine learning/artificial intelligence in diagnosing, monitoring, and treating OCD.
I am recruiting individuals who meet these criteria:
- You are a licensed clinician (e.g., psychiatrist, psychologist, therapist) who treats individuals with OCD.
- You are over 18 years old.
If you decide to participate in this study, you will be asked to do the following activities:
- Complete a brief phone screening to confirm you are eligible to participate by answering questions about your clinical licensing, practice setting, and percentage of patients treated with OCD and reviewing the eligibility criteria as listed above.
- Participate in a 1:1 online interview over Zoom for approximately 60 minutes.
During these activities, you will be asked questions about:
- Your demographic information including age, gender, race, and ethnicity
- Your professional credentials, clinical practice setting, and patient/client panel
- Your experiences with and opinions on using wearable devices, smartphone apps, and machine learning/artificial intelligence in diagnosing, monitoring, and treating OCD
After you complete the 1:1 online interview you will receive a $50 Tango gift card sent to your preferred email address.
If you are interested in participating in this study, please contact me at: adam.frank@med.usc.edu or (323) 442-4042.
Thank you!
Adam Frank, MD, PhD
-
Must be a parent or a caregiver of a child, or adolescent that is diagnosed and in treatment for anxiety, or OCD (obsessive compulsive disorder).
-
Must be willing to complete a brief survey/ questionnaire (solely remotely).
Sincerely,
Natalia Betancur Henao, LCSW, MSW, BSW
Tulane DSW Candidate (2025)
Hello,
Please consider taking part in our research study on marginalized clients’ experience of evidence-based therapy at the University of Louisville, Department of Psychological and Brain Sciences. The purpose of the study is to learn about why marginalized clients might not benefit from evidence-based treatment and assess their treatment needs.
Click here to learn more about the study: https://redcap.link/FailureToTreat.
Eligibility criteria:
- Identify as part of any marginalized or underrepresented* group
- Received therapy (e.g., cognitive behavioral therapy, mindfulness-based, exposure) AND did not find therapy helpful
- At least 18 years old
- English fluency
- Reliable internet access
*By “marginalized,” we mean anyone who’s ever felt excluded or treated unfairly because of who they are—whether it’s your race, gender, sexuality, background, or something else.
Procedures (all online):
- Initial screening survey to determine eligibility for continuing to participate (5–10 min)
- One-on-one recorded interview with researcher (90 min)
- Online questionnaires on psychological functioning (20–30 min)
Participants will be compensated for their time. Thank you in advance for considering this request. For more information, please email Clarissa Ong (study PI) at clarissa.ong@louisville.edu.
- Reside in the United States
- Self-identify as Black American
- Self-identify as having OCD
- Are comfortable disclosing experiences of racism
The oral medicine dextromethorphan (brand names including Robitussin, Delsym) has long been used as an over-the-counter non-prescription treatment for cough. In recent years, it has also been combined with other medicines to create FDA-approved prescription treatments: Neudexta for neurologic disorders and Auvelity for major depressive disorder. Dextromethorphan has a glutamate-based mechanism of action that suggests it may be a helpful medicine for OCD and related disorders, though it has never been studied as an OCD treatment. We are testing whether the combination of dextromethorphan and fluoxetine (Prozac) may decrease symptoms of obsessive-compulsive and related disorders. We are seeking individuals between 18 to 65 with symptoms of OCD, body dysmorphic disorder (BDD), illness anxiety disorder (IAD), or somatic symptom disorder (SSD) to take part in an eight-week, open-label study of the combination of fluoxetine and dextromethorphan vs fluoxetine alone. Eligible participants may be using fluoxetine currently or not taking any medication. This study is fully remote, with all assessments and study visits taking place via secure videoconference.
Funding: The Miller Foundation
Enrolling: Ongoing, fully remote
Please contact us about participating at: ocdresearch@stanford.edu; 650-723-4095; https://med.stanford.edu/rodriguezlab/research
Do you experience persistent and distressing doubts about your partner and/or relationship? Do you try to minimize these doubts by seeking reassurance or checking whether your relationship feels right? These doubts and behaviours may be symptoms of relationship obsessive-compulsive disorder (ROCD), which is a mental health condition involving obsessions and compulsions regarding romantic relationships. The aim of this study is to understand the impact of ROCD symptoms on couples’ sexual well-being. Results from this study may be used to inform treatment for couples navigating these challenges.
To participate you and your partner:
- Must be 18 years or older and have been in a romantic relationship for at least one year.
- You and/or your partner experience persistent and distressing doubts about your relationship or report ROCD symptoms.
Couples of all gender/sex identities and sexual orientations are encouraged to participate.
Participation includes each member of a couple completing an approximately 45-minute online survey.
This research is being conducted at the University of Prince Edward Island by doctoral student Brenna Bagnell and is supervised by Dr. Martha Giraldo O’Meara.
For more information please complete our screening survey https://tinyurl.com/rocdstudy or email Brenna Bagnell at omearalab@upei.ca.
Do you identify as Black, African American, Afro-Latinx, Afro-Caribbean, or of mixed African ancestry? Do you experience anxiety regarding intrusive, obsessive thoughts or compulsive behaviors?
The OCD and Related Disorders Program at Baylor College of Medicine is conducting a study exploring the lived experiences of Black Americans with obsessive-compulsive disorder (OCD). The purpose of this study is to examine attitudes toward OCD symptoms, OCD-related stigma, challenges with treatment access, and strengths among Black adults with OCD. This will help us understand OCD within the Black community, develop a culturally informed, online psychoeducational program, and diversify OCD research.
You may be eligible for this study if:
- Identify as Black/African American, Afro-Latinx, Afro-Caribbean, and/or mixed race, including Black
- Have been diagnosed with OCD at some point in your life or currently experiencing symptoms you think might be OCD OR have a family member with OCD
- Age 18-89 years old
- You are English speaking
- Are a clinician treating OCD among Black youth and adults
What's Involved?
- Completion of a phone screening, clinical assessment, demographic and mental health questionnaires
- Participation in a one-time, virtual focus group
- All collected information and assessments are kept securely
- $50 compensation when completed
Please visit https://redcap.link/theblocproject or contact Ogechi Onyeka, Ph.D. (Principal Investigator) at theblocproject@bcm.edu for more information.
- Adults aged 18 and older who can provide their own consent.
- Diagnosed with OCD by a medical or mental health professional.
- Able to read and understand English.
-
At least 18 years old
-
Living in the United States
-
Fluent in English
-
Access to a device with Internet access
-
Seeking/sought treatment for anxiety, OCD, emotion dysregulation, and/or BPD in the past year
Have You Undergone Neurosurgery for OCD?
Researchers at Butler Hospital are conducting a survey to better understand the experiences of individuals who have received neurosurgical procedures for the treatment of Obsessive-Compulsive Disorder (OCD). Your participation will help improve future interventions for individuals with severe OCD.
Who Can Participate?
- Adults (18 years or older) who have received neurosurgery for OCD, including procedures like Cingulotomy, Capsulotomy, Deep Brain Stimulation, and others.
What’s Involved?
- A brief anonymous survey about your experiences and attitudes toward different interventions for OCD. The survey will take approximately 10–15 minutes to complete.
Compensation:
- Participants who complete the survey can enter a drawing to win 1 of 50 $20 Target gift cards.
Confidentiality:
- Your responses are completely anonymous, and your name and email (if provided for the raffle) will be kept confidential and separated from the survey data.
To Participate:
- Please first fill out this pre-screening and e-consent form to determine your eligibility: https://redcap.carene.org/surveys/?s=TADKALJH7D
For any questions, feel free to contact the research team at nmclaughlin@butler.org or 401-455-6608.
Thank you for your time and participation!
Researchers at the University of Kentucky are looking for volunteers who have begun exposure-based OCD treatment and have experienced interpersonal violence (physical, sexual, or emotional assault or abuse) to participate in a research study. Participants will complete a set of online questionnaires (~30 minutes) and a 90-minute interview (online via Zoom). Compensation will be provided. A brief online survey and phone screen are required to determine eligibility.
You may be eligible to participate if you:
- Are 18 or older
- Have begun exposure-based therapy for OCD within the past 24 months
- Have experienced physical, sexual or emotional abuse
Participants will be offered:
- You can earn up to $50 for study participation.
To see if you are eligible, go to the following website: www.tiny.cc/ukyresearch or contact Emily Fenlon (emily.fenlon@uky.edu) to learn more.
Do you experience chronic pain, or have a history of pain more generally speaking?
We are inviting you to take part in a research study exploring how personality traits, resilience, positive outlook and obsessive-compulsive symptoms may influence behaviours related to chronic pain. Your participation could provide valuable insights into the relationship between psychological factors and pain management.
If you are interested in participating, please complete the questionnaire linked below. It should take approximately 20 minutes, and your responses will remain anonymous. Participation is entirely voluntary, and you may withdraw at any time before submitting your answers, with no consequences.
https://app.onlinesurveys.jisc.ac.uk/s/ulster/chronicpain
For any questions or further information, please feel free to contact us:
Dr. Ellen Henderson: E.Henderson1@ulster.ac.uk
Monika Maminskaite: Maminskaite-M@ulster.ac.uk
Have you been diagnosed with obsessive-compulsive disorder (OCD) by a mental health professional (e.g., a psychologist, physician, or therapist)? Are you aged 18 or above and living in Canada or the United States?
If you answered “Yes” to the questions above, we invite you to participate in an approximately 20–25-minute online survey about your experiences with how obsessions spread.
As appreciation and compensation for your time completing the survey, you can choose to be entered into a raffle for the chance to win one of 20, $100 e-gift cards.
Your participation is greatly appreciated, as it helps us better understand the mechanisms of symptom spread in obsession-compulsive disorder.
If you are interested in participating in this study and meet the eligibility criteria noted above, you may access the survey here:
https://mun.az1.qualtrics.com/jfe/form/SV_77llN5xe8qzxOrI
If you would like more information about this study, please contact the principle investigator, Brooke Hiscock (bbhiscock@mun.ca) or her supervisor, Dr. Emily Fawcett (efawcett@mun.ca).
This research has been approved by the Interdisciplinary Committee on Ethics in Human Research (ICEHR). If you have ethical concerns about the research, such as the way you have been treated or your rights as a participant, you may contact the ICEHR at icehr@mun.ca or by telephone at 709-864-2861.
Researchers at Rogers Behavioral Health are interested in learning about mental health providers’ perspectives on using exposure and response prevention (EX/RP) to treat “not just right” and disgust symptoms in OCD. If you are a mental health provider, we would be grateful if you would share your perspective in a brief online survey.
You are eligible and invited to participate if you:
- Are a mental health clinician (includes trainees)
And, - Have treated OCD with exposure and response prevention (EX/RP) therapy
The survey takes about 10-15 minutes to complete. Upon completion, all participants will be entered into a raffle to win one of ten $50 Amazon gift cards.
Please click on the following link to start the survey: https://nam.dcv.ms/Uaq6ZEDlaU
This study has been approved by the Institutional Review Board of Rogers Behavioral Health. The Principal Investigator is Dr. Rachel Schwartz, Associate Research Psychologist. Please contact Dr. Schwartz at Rachel.Schwartz@RogersBH.org with any study related questions.
Do you identify as Black/African American, mixed race including Black, or have at least one grandparent who identifies as Black/African American?
Have you ever been diagnosed with OCD or are you currently experiencing symptoms you think might be OCD?
If so, you may be interested in our new research study, BELONG! BELONG is a study that aims to create a better understanding of the clinical aspects of OCD (for example, when your symptoms started, the types of symptoms you have, what has helped you, or not helped, to get relief from your OCD, etc) and the genetic/neurogenomic characteristics of OCD, in individuals with Black or African ancestry.
Anyone between the ages of 5 and 70 may participate.
Participants will receive compensation for their time.
If interested in participating in our study, please contact BELONG@mssm.edu for more details.
Researchers from Victoria University would like to hear from adults (18+) with symptoms of OCD who are interested in taking part in research on the relationship between the mind-body connection and the sensory experiences that often accompany compulsions. It is hoped that this research will provide insight into these ‘sensory phenomena’ to guide the development of future alternative treatments for OCD that directly address the mind-body connection.
Participation will involve a confidential online survey (~30 minutes) that will ask about your obsessive-compulsive symptoms, any sensory experiences that may trigger or accompany your compulsions, and your mind-body connection, including how you use your bodily sensations to guide your behaviour.
To take part or learn more, click on the link below or contact student researcher, Lizzie Wilson: lizzie.wilson1@live.vu.edu.au
Survey link: https://vuau.qualtrics.com/jfe/form/SV_8zYpWHuGNpAksKi
This survey was designed by the Pediatric OCD Program at BC Children’s Hospital. We’re looking for your opinions on OCD research study participation to identify what makes someone more or less likely to sign-up. We hope this will improve intervention research for OCD by optimizing design and recruitment efforts of future studies.
What happens in this study?
This survey has questions about demographics, medical and psychiatric background, and opinions on participation in research studies and medication treatment trials.
Each survey takes 10-20 minutes to complete. Your child may also participate and complete a survey themselves. Participation is entirely online; you may save and return to the survey at any time. All participants who complete the survey will be entered to win one of five $50 gift cards.
Who is eligible for this study?
- Parent/guardian of a child with OCD diagnosed by a healthcare provider, or
- Young person ages 8-18 with a diagnosis of OCD made by a healthcare provider
- Living in Canada or the United States
How can I get involved?
For more information on the study or how to participate, visit our study webpage: https://www.bcchr.ca/POP/our-research/research-perspectives-survey
Overview: Researchers at the Program for Anxiety, Stress, and OCD (PASO) lab at the University of Miami are recruiting for our new research study, the Online Therapy for OCD Study. Learn more below or at https://pasolab.org/participate-in-research/online-treatment-ocd-study/.
What the study includes: If you are eligible for this study, you will receive 2-3 months of free, online, and effective cognitive behavioral therapy for OCD through OCD-NET (https://www.ocd-net.com/). You will be assigned an individual therapist who supports you and who you can message in the OCD-NET platform. Before you begin treatment, you will have a couple short Zoom sessions to conduct a clinical interview and to onboard you to the treatment.
During treatment, you will do exposure and response prevention exercises. As part of this study you will complete daily entries in an online survey we designed to help coach you through your exposures. This tool is called OLIE, the OCD Logbook for Intentional Exposure.
You will also complete weekly questionnaires through the OCD-NET platform. At the end of the study, you will complete another short Zoom interview.
Eligibility: You may be eligible to participate if you are in the US, between the ages of 18-90, you have OCD, and you can commit for up to 2-3 months of self-paced, online therapy.
Compensation: In addition to receiving the free treatment, you will be compensated up to $150 for completing various parts of the study such as the questionnaires, the final interview, and the OLIE online survey.
How do I participate?: To see if you are good fit, click here to fill out our study contact form: https://redcap.miami.edu/surveys/?s=CTF4HPW7TTT3JRAP
Or, learn more at our website (https://pasolab.org/participate-in-research/online-treatment-ocd-study/). You can also contact us at pasolab@miami.edu or (305)-284-5394. Thank you!
What is this study about?
The Treatment and Assessment of Cognitive Effectiveness (TRACE) Lab at Alliant International University, San Diego is interested in understanding how cognitive skills can be impaired and repaired in parents of children affected with OCD.
What will I need to do?
Participation will involve completing a one-time 10 minute online survey followed by a 1 hour zoom meeting.
Why should I participate?
Participants will receive compensation in the form a $25 gift card and an entry into a drawing for a $150 gift card. Additionally, your participation can help us reach our goal to better serve parents and their children with OCD and inform treatment outcomes.
How do I participate?
Copy and paste this link to start the initial survey: https://alliant.qualtrics.com/
I am in the final year of the DSW program at the University at Buffalo and the capstone research project I have developed will focus on the uptake of an evidence-based practice for the treatment of OCD among clinicians in private practice.
I am passionate about ending the suffering associated with OCD, one of the most debilitating mental health disorders on the planet. The I-CBT approach is an evidence-based approach and an alternative to traditional exposure therapy that focuses on addressing the trans-diagnostic concept of inferential confusion.
What is it? A 6-session (12 hour) time commitment among clinicians in private practice to meet virtually to learn and practice the Inference-Based Cognitive Therapy approach to treating OCD. Check icbt.online for more information about the approach.
What's it cost? It's completely free of charge.
What is being studied? The degree to which clinicians in private practice develop self-efficacy (defined by Bandura (1997) as competence, confidence and motivation to do something) as a function of their participation in a virtual professional learning community.
How are you studying that? Through the use of qualitative and quantitative survey results garnered at two points in the 6 weeks, and one month afterwards as well as through anonymous knowledge checks given during each session.
What will we do? We will meet together with myself as the facilitator in a small group of about 15 clinicians and learn the I-CBT approach to treating OCD on 6 occasions for a total of 12 hours. We will meet in a zoom room and use lecture, video, case study and small group practice to begin to understand the concepts of the I-CBT approach.
What are the eligibility requirements? Only that you are a licensed clinician in private or small group practice that has not had any formal training in the I-CBT approach.
What do I do if I am interested? Send me an email at fkuehn@buffalo.edu. I will send you an informed consent document and a link to a google form where you can indicate your preferred/available meeting times. I will then gather the most people available and contact them directly to confirm participation.
This research study is focused on helping to increase awareness regarding the large number of ways that OCD can present, with the aim to lead to greater OCD education and to reduce OCD-related stigma.
The survey is for adults (18 years or older) who have OCD (with or without a formal OCD diagnosis). The survey takes between 10 and 20 minutes to complete and is completely anonymous. The study is approved by Wright State University’s IRB. Study participants are welcome to enter the study drawing. Ten participants will be randomly selected and will each receive a $30 VISA gift card.
Please find below the link to the survey.
https://mun.az1.qualtrics.com/jfe/form/SV_0IfpyDnwpATBnJs
Sincerely,
Kimberly Leonte, PhD and Natalie Grierson, PhD, LPCC-S, Emily Fawcett, PhD & Lydia Hardy
Researchers at Penn State University are interested in learning more about the relationship among sleep patterns, thoughts, behaviors, and emotions in OCD. The findings from this research may help improve understanding of mechanisms that maintain obsessive-compulsive symptoms and improve interventions by targeting them in treatment. This project will offer you the opportunity to receive an Amazon e-giftcard of up to $50.00 as compensation.
This study has three parts:
- In the initial assessment visit, we will administer a videotaped in-person clinical interview and a brief questionnaire to determine if you are eligible to participate in our study. This will take approximately 20-30 minutes. If you are eligible and decide to continue in the study, there will be additional questionnaires (taking approximately 25 minutes) and a brief ½ hour training session where we will instruct you in the use of a mobile application for completing daily surveys and wearing a sleep watch. The initial visit will take place over Zoom.
- For the next 7 days, you will complete seven 4 minute questionnaires per day and monitor your sleep by wearing a sleep watch (that will be sent to you by mail) and maintaining a daily sleep diary.
- On day 4, there will be a brief compliance check Zoom visit where you will be informed about your overall compliance rate.
- At the end of the study, you will receive a pre-paid shipping label to return the sleep watch to us and will receive an Amazon e-giftcard as compensation based on your study compliance.
For more information, please contact Valerie Swisher at vss5199@psu.edu
PARTICIPATE IN OUR STUDY ON HALLUCINOGENS & OCD!
Have you ever experienced symptoms related to Obsessive Compulsive Disorder (e.g., intrusive thoughts or compulsions)?
Have you ever used a hallucinogenic drug (e.g., LSD, Psilocybin, Ketamine, MDMA or similar substances)?
Researchers at Macquarie University (Australia) are running a study investigating the relationship between hallucinogens and OCD. We would like to better understand how drug induced alterations in consciousness might impact on OCD symptoms. If you have had experience in this area, we would like to invite you to take part in our research.
What happens in the study: You will be asked to complete an online survey and may also be invited to take part in an online interview. We will ask questions about your experience of OCD symptoms and experiences with hallucinogenic drugs.
Who can take part? You must be 18 years or older, fluent in English, have experience with a hallucinogenic substance, and experience OCD symptoms.
Where and for how long: This study will be completed online. The survey will take roughly 30 minutes to complete. The interview will take up to 60 minutes.
Are there any financial benefits for participating? Participants who take part in the study will be entered into a prize draw to win one of three $100 gift vouchers.
Who to contact? If you have any questions or concerns about the study, please contact Dora Szabo (dora.szabo@students.mq.edu.au), All information that you provide will be kept anonymous and confidential. This project has been granted ethical approval from the Macquarie University Medical Sciences HREC: 520231641854696.
Survey link: https://mquni.au1.qualtrics.
Consumer and Clinician Perspectives on the Treatment of OCD among People with Lived Experience of OCD Symptoms with a History of Trauma Exposure
IRB-23-10-6223
Have you experienced past or current symptoms of OCD and been exposed to at least one traumatic event?
If so, you may be interested in this research study aimed at better understanding the relationship between OCD, trauma, and mental health treatment.
We are conducting a research study to better understand:
- perspectives and treatment experiences of people with OCD who have a history of trauma exposure
- the relationship between dissociative symptoms and OCD
- the relationship between different types of trauma exposures and types of OCD
What does participation look like?
You will be asked to complete a one-time, online survey assessing OCD symptoms, trauma history, and your treatment experiences. This survey that will take about 25-50 minutes of your time.
Participants who complete this survey can choose to be entered into a lottery for a drawing for gift card incentives valued at $30.
If you are interested, please use this link for a brief pre-screening survey. If eligible, you will be taken directly to the survey to complete it. Thank you!
https://waynestate.az1.qualtrics.com/jfe/form/SV_a8X7LB6cotxnqxE
Consumer and Clinician Perspectives on the Treatment of OCD among People with Lived Experience of OCD Symptoms with a History of Trauma Exposure
IRB-23-10-6223
Have you treated individuals with OCD who have also been exposed to at least one traumatic event?
If so, you may be interested in this research study aimed at better understanding the relationship between OCD, trauma, and mental health treatment.
We are conducting a research study to better understand:
- clinician’s perspectives on treatment responses of people with OCD who have a history of trauma exposure
- the relationship between dissociative symptoms and OCD
- the relationship between different types of trauma exposures and types of OCD
What does participation look like?
Participation involves a one-hour interview via Zoom to discuss your experiences, challenges, barriers, and any successful strategies you have used in practice when providing treatment experiences to people diagnosed with OCD who have a history of trauma exposure.
After completing the interview, you will receive a $40 gift card incentive.
If you are interested, go to the link below for a brief pre-screening survey. If you are eligible for the study, a research assistant will reach out to schedule an interview. Thank you!
https://waynestate.az1.qualtrics.com/jfe/form/SV_3k4U8KenWCu1xfE
Would you like to take part in an online survey investigating the effects of inflexible thinking styles on engagement in treatment?
Hello, my name is Shaunak Deshpande. I am a trainee clinical psychologist. As part of my doctoral training in clinical psychology at Hertfordshire University, I invite you to participate in my research exploring how flexibility in thinking can influence well-being and adherence to therapies.
It should take around 20 minutes.
Have you been diagnosed with OCD or a related disorder (e.g., Body Dysmorphic Disorder, Hoarding Disorder, Hair-pulling or Skin-picking Disorder) or an Eating Disorder?
Are you aged 18 years or above?
Have you received some form of therapy or medication for your mental health in the last 12 months or are you currently receiving it?
Please contact me or use the following link: https://tinyurl.com/95t228cd
Shaunak Deshpande: s.deshpande@herts.ac.uk
Recruiting Individuals with OCD
Modern technologies such as wearable biosensors, smartphone apps, and machine learning/artificial intelligence (ML/AI) are starting to be used in medicine and psychiatry for diagnosis, symptom monitoring, and treatment. Individuals with OCD have unique experiences and perspectives related to their mental health and we are interested in your perspective on these modern technologies.
Study Goal: The goal of this study is to assess the perspectives of individuals with OCD on the use of wearable biosensors, smartphone apps, and ML/AI in diagnosing, tracking, and treating OCD.
Study Methods: Participation will involve completing an approximately 60-minute virtual interview with study personnel about your thoughts, hopes, and concerns for the use of modern technologies in changing how OCD is diagnosed and treated. You will be asked for your opinions and experiences and there are no right or wrong answers during this interview.
Participants will receive compensation in the form of a $50 Amazon gift card for their time and effort.
For more information and to see if you are eligible to participate, please contact:
Dr. Adam Frank (adam.frank@med.usc.edu), study Principal Investigator or study personnel by phone/voicemail at (323) 442-4042
Study description: We are seeking participants with symptoms of obsessive-compulsive disorder to participate in a trial investigating the acceptability and feasibility of a stepped care treatment for obsessive-compulsive disorder.
This is an open trial where all participants get immediate access to the treatment. The treatment is provided free of charge.
The stepped care treatment includes two steps. The first step involves a low-intensity treatment, a cognitive behavioral therapy workbook with email support from a psychologist, delivered over 8 weeks. Participants that do not make significant improvements in symptoms will commence the second step, a higher intensity treatment. The second step involves 8 weekly sessions of cognitive behavioral therapy with a registered or provisionally registered psychologist via Zoom, a videoconferencing platform.
Participants will be asked to complete brief self-report questionnaires, and will be administered semi-structured interviews via Zoom, to measure symptoms at pre-treatment, mid-treatment, post-Step 1, and post-Step 2.
Eligibility criteria:
To be eligible for the study participants are required to be:
- English speaking
- Aged 18 years or older
- Have regular access to the internet
- Meet criteria for obsessive-compulsive disorder
Interested participants can find out more about the study at the TelePsych website (https://www.uts.edu.au/about/graduate-school-health/clinical-psychology/what-we-do/clinical-psychology-research/telepsych-laboratory).
The study is approved by the University of Technology Sydney Health and Medical Research Ethics Committee. Approval Number: ETH22-7391. Valid to: 15/02/2028.
We need volunteers to take part in an online study looking at why obsessive-compulsive disorder (OCD) therapy works or fails.
Participants will be asked to complete questionnaires, interviews and play computerized games. Knowing the brain causes of why OCD therapy does not work for everyone will ultimately help us improve treatment outcomes. You will receive £8.50 an hour (~ 40 USD per session) as compensation.
We are looking for volunteers who are:
- Experiencing OCD
- Aged 18-55
- Fluent in English
- Normal/corrected vision
- Starting OCD therapy
Interested? Contact the research team at k.hoang@ucl.ac.uk (Karen Hoang) or t.seow@ucl.ac.uk (Dr Tricia Seow) for further details.
Feeling overwhelmed by “simple” tasks? Having trouble getting things done? Criticizing yourself over small mistakes? Feeling stressed about constantly needing to meet high or unrealistic expectations?
You may be struggling with perfectionism. The POIS Lab at the University of Toledo and Personalized Mental Health Lab at Southern Illinois University are testing the effects of two self-help interventions for perfectionism. You can choose how much time to spend on the intervention over a 1-month access period.
As part of the study, you will also be given surveys to complete every week (10–15 min each, 5 total) and 1 month and 6 months after the access period. You may receive up to $65 for completing the study surveys.
If you’re interested in learning more about our research, click here to take a brief screening survey: https://bit.ly/goodenoughstudy!
We are a group of researchers at the Department of Computer Sciences, University of Wisconsin-Madison. We are developing wearable technologies to help people better manage their OCD in their daily life, and we need your help.
You are eligible if:
1. you are over 18, and
2. you were diagnosed with mild to moderate OCD, and are willing to talk about them with us.
If you agree to be in the study, you will be interviewed via zoom by our research team regarding your OCD condition, strategies to manage your OCD, experience of OCD therapies, and assistive technology (if any). Each study session will last no longer than 90 minutes. You will receive compensation at a rate of $20/hr for participating in our study.
During the study, we will record the video of the interview. All the data collected will only be used for research purpose within our research team at UW-Madison, and NO personally identifiable data will be shared to any other entity.
If you are qualified and interested in participating, please contact us by filling out a survey: https://forms.gle/hFz3vzPHyra8JMYE8 or contact ru.wang@wisc.edu
Thank you!
The MAP Lab at Mississippi State University is running an online study testing whether two prototype mobile apps can help people with clutter and/or hoarding problems to declutter. You might be interested in this study if you have difficulty letting go of belongings or feel like you have a lot of clutter. Participation involves completing 3 online surveys over the next 8 weeks, and being randomly asked to either use a prototype mobile app (by responding to brief questions and engaging in writing exercises twice daily) for four weeks, or being asked to wait for 8 weeks before using one of the prototype apps.
To be eligible you must be 18 or older, live in the US, own an iOS or Android mobile device (such as a smartphone or tablet), and have significant problems with clutter and/or hoarding.
You can find out more about the study at https://maplab.squarespace.com/writing-app.
Participating is completely voluntary, and you can withdraw from the study at any time. This study has been reviewed by the Mississippi State University HRPP/IRB, is designated IRB-23-253, and has been granted an Exemption Determination. The principal investigator is Dr. Jennifer Krafft (jek299@msstate.edu). Please contact Natalie Tadros (nt546@msstate.edu) with any questions.
Dear Caregiver,
I hope this message finds you well. I am writing to invite you to participate in an important online survey titled “Exploring the Relationship Between Duration of Caregiving and Quality of Life, Caregiver Burden, and Prevalence of Psychiatric Disorders in Caregivers of Individuals with OCD.” Your unique experiences and insights are invaluable to us.
What is the Survey About?
This survey is part of a research study aimed at understanding the challenges faced by caregivers like you. We are particularly interested in exploring how the time you dedicate to caregiving impacts your quality of life, the burden you might feel, and the prevalence of any stress-related psychiatric conditions. Your participation could be instrumental in shaping better support systems and resources for caregivers.
Who Can Participate?
If you are currently over 18 and a caregiver for someone with obsessive-compulsive disorder (OCD), we would be grateful for your participation. Your experiences, both challenges and triumphs, in this caregiving journey are crucial for our study.
What Will I Need to Do?
Participation involves completing an online survey that should take approximately 10-12 minutes. The survey includes questions about your caregiving experiences, your well-being, and any stress you may be experiencing. Rest assured, your responses will be confidential and anonymised and will contribute significantly to our understanding of caregiver experiences.
Why Should I Participate?
Your input will provide valuable insights into the caregiving experience and help identify key areas where caregivers need more support. By sharing your story, you can contribute to research that may improve the lives of countless caregivers.
How Do I Participate?
To participate, simply click on the link below.
https://wolverhamptonpsych.eu.qualtrics.com/jfe/form/SV_7WzcrpzHpAN4cgm
Thank You
We deeply appreciate your consideration to participate in this study. Your voice matters, and your experiences can make a real difference in the lives of caregivers and the ones they support.
If you have any questions about the study, please contact lead researcher A.cowpar@wlv.ac.uk. Or her supervisor G.roberts11@wlv.ac.uk
Warm regards,
Alison Cowpar
Lead researcher
A.cowpar@wlv.ac.uk
Wolverhampton University.
Does your child have PANS/PANDAS?
Researchers at Baylor College of Medicine are interested in parents of children with PANS/PANDAS perceived acceptability of treatment types. This study involves a brief, anonymous questionnaire about your experiences of PANS/PANDAS treatment.
To participate, please visit: https://redcap.link/
For more information, please contact megan.dailey@bcm.edu (sending information via email is not secure, please refrain from including any personal information in email correspondence).
Do you have OCD? Are you over 18 years old? Have you disclosed your OCD to others?
Researchers at Baylor College of Medicine are interested in the experiences of disclosure in individuals who have obsessive-compulsive disorder (OCD). The study involves a brief, anonymous questionnaire about your experiences of and attitudes toward disclosure and your OCD symptoms.
To participate, please use the link below or scan the QR code on the flyer: https://bcmpsych.sjc1.qualtrics.com/jfe/form/SV_cUeP1Mhm7R8eGKW
For more information, please contact Molly Church at molly.church@bcm.edu
Thank you for your time and participation!
NOTE: Health information shared online is not secure. Please do not comment on this post with any private or personal health information.
Living with OCD in the United States? Participate today in the 10-minute National OCD Survey!
Is OCD impacted by:
- Where you live?
- What you value?
- Who you've met?
- What you believe?
Baylor College of Medicine is launching what we are hoping will be the largest, most nationally representative survey on OCD to date – the National OCD Survey. Our goal is to reach as many adults with OCD as possible in all 50 U.S. states so that we can better understand the impact of sociocultural and regional influences on OCD.
Please consider completing this brief (10-minute), anonymous online survey at https://bcmpsych.sjc1.qualtrics.com/jfe/form/SV_9LdbaR2yrj0oV7g or email NationalOCDSurvey@bcm.edu for questions.
You are invited to participate in a research study being conducted by an investigator from The University of La Verne. Approved by the Institutional Review Board, # 2023-06-CAS. The purpose of the study is to understand the experiences of family members (both adolescents and their parents) in relation to skin picking disorder. A benefit from participating in this study is that you will be assisting the field of psychology in gaining greater information about Body Focused Repetitive Behaviors (BFRBs) while providing support for future families. To participate your child must be between the ages of 12 and 17 years old, speak English, live in the United States, participate in the interview in the United States, and have a legal guardian available to participate in the study with them. In addition, your child must meet criteria for a diagnosis of skin picking disorder and be currently seeing a therapist or on a waitlist to see a therapist. However, the legal guardian is not required to meet criteria for skin picking disorder. The location of the study will occur virtually over zoom.
To ensure you and your child meet criteria, you will be screened for basic demographic and diagnostic information after contacting the principal investigator. If you agree to participate, you will take part in an interview via Zoom. This interview will take approximately 60 minutes. Your child will be asked to share personal experiences about their skin picking in relation to the home setting. Legal guardians will be asked to participate in an additional interview that will take approximately 60 minutes in which they will share their experiences of observing their child engage in skin picking in the home setting.
Another benefit to participating in this study is that both adolescents and their legal guardians will each individually receive $15.00 (in the form of a gift card) for completion of the interview. Taking part in this research study is completely voluntary, and participants may terminate at any time.
If you wish to participate in this study or have questions, please contact Gwen McInnes
at gwendolyn.mcinnes@laverne.edu. Thank you for your consideration and I look forward to hearing from you!
California
This study explores whether the drug RR-HNK (a metabolite of ketamine that has no anesthetic and dissociative activity) relieves symptoms of OCD, such as repetitive thoughts and behaviors. Eligible participants with OCD (ages 18-65) will be randomized to receive a single infusion of RR-HNK or the placebo (saline), with EEG (brain wave) recording before and after the infusion. OCD symptoms will be monitored for 4 weeks.
Funding: Donor Funding
Enrolling; Sep 2025- Jul 2027, in-person
Please contact us about participating at: ocdresearch@stanford.edu; 650-723-4095; https://med.stanford.edu/rodriguezlab/research
This study investigates the safety, feasibility, and preliminary efficacy of MDMA-assisted cognitive behavioral therapy (CBT) in participants with OCD. Eligible participants (ages 18‒65) with OCD will be randomized to receive either a single dose of MDMA or an active control drug plus 10 exposure therapy sessions over the following two weeks. OCD symptoms will be monitored for 4 weeks after the completion of therapy. This study will require 2-3 in-person visits; the remaining follow-ups will be completed remotely via secure videoconference.
Funding: New Venture Fund
Enrolling; Sep 2025- Jul 2027, in-person
Please contact us about participating at: ocdresearch@stanford.edu; 650-723-4095; https://med.stanford.edu/rodriguezlab/research
The purpose of this study is to test whether noninvasive, brief activation of the vestibular (balance) system may influence the strength of obsessive thoughts and relieve distress. Participants (ages 18 ‒ 65) with a diagnosis or symptoms of OCD or the related disorders body dysmorphic disorder (BDD), illness anxiety disorder (IAD), or somatic symptom disorder (SSD) will undergo eligibility screening, including psychological evaluation and a physical exam. Study participation is anticipated to last 3 days; involves noninvasive stimulation of the vestibular (balance) system, an EEG (electroencephalogram) recording during a computer-based test of attention, and a psychological assessment; and is compensated.
Funding: Stanford Department of Psychiatry and Behavioral Sciences
Enrolling: Ongoing, in-person
Please contact us about participating at: ocdresearch@stanford.edu; 650-723-4095; https://med.stanford.edu/rodriguezlab/research
Building on our lab’s prior work showing ketamine brings about rapid (within hours) reduction of OCD symptoms in half of those who receive a single dose of ketamine, this study will be the first to test ketamine’s opioid properties in modulating fronto-striatal cognitive control circuits and anti-obsessional effects. Eligible participants with OCD (ages 18 ‒ 65) will receive a single infusion of low-dose ketamine, randomization to either pill placebo or drug that blocks opioid pathway, and two MRI brain scans. After completing research procedures, participants with OCD may be eligible for treatment through our clinic or research studies.
Funding: National Institute of Mental Health (NIMH)
Enrolling: Fall 2023- Spring 2028 (5-year study), in-person
Please contact us about participating at: ocdresearch@stanford.edu; 650-723-4095; https://med.stanford.edu/rodriguezlab/research
Personalized DBS for OCD Guided by Stereoencephalography Mapping
ClinicalTrials.gov Identifier: NCT06347978
We are conducting a research study into personalized deep brain stimulation (DBS) for Obsessive-Compulsive disorder (OCD) at the University of California, San Francisco (UCSF), which will be guided by invasive brain mapping.
We are looking for a total of 10 adult patients with treatment-refractory OCD.
If you are eligible and choose to be in this study, there will be three stages, including invasive brain mapping, placement of a 4-lead DBS system, and a randomized trial to determine the therapeutic effects of DBS On compared to DBS Off. Stage 3 will be followed by open label stimulation for an additional 6 months.
The total duration of the study is about 36 months. You should expect to be followed for up to 6 months beyond this point.
The purpose of this study is to determine if personalized deep brain stimulation (DBS) based upon invasive brain mapping is safe and can lead to better outcomes. The information we obtain in this study will be used to better understand the parts of the brain involved in Obsessive Compulsive Disorder (OCD). This study is led by Drs. A Moses Lee and Andrew Krystal.
Please email ocdresearch@ucsf.edu if you are interested in participating or have any questions about the study.
Improv comedy is a type of theater (e.g., games or scenes) in which actors perform without a script. It has been shown to have positive outcomes for treating patients with a variety of psychiatric symptoms. However, no study to date has investigated the effects of an improv comedy-facilitated intervention for individuals diagnosed with OCD. Exposure and response prevention (ERP) is the gold-standard treatment for OCD. We are seeking patients with OCD who are interested in participating in a novel ERP + Improv Group Therapy for OCD. This intervention will augment ERP with improv comedy activities.
Participants with OCD (ages 18 and over) will receive a psychological evaluation to determine eligibility for the study. In the study, all participants will receive weekly 90-minute group therapy for 12 consecutive weeks, answer questions about OCD symptoms, and complete questionnaires. Compensation will be provided for time and travel.
Start Date: January 22, 2025
Please contact us about participating at: ocdresearch@stanford.edu, 650-723-4095
As many as 50% of children and adolescents with Obsessive Compulsive Disorder (OCD) experience continuing significant and impairing symptoms even after receiving medication and cognitive-behavioral therapy.
The goal of this pilot study is to explore if adding Transcranial Magnetic Stimulation (TMS) to ongoing treatments can lead to further improvement and even remission of OCD in teens who have experienced limited or no response to usual treatment with medication and/or cognitive-behavioral therapy (CBT).
TMS is FDA-approved for treatment resistant OCD in adults, and is safe in children and teens, but TMS has not been carefully studied in adolescent OCD.
If eligible, all adolescents in the study will receive a 3-week intensive TMS treatment under close monitoring as well as an MRI of the brain before and after TMS.
This project’s goal is to determine whether treatment with TMS administered to one of two assigned stimulation sites proves to be acceptable and shows some evidence of benefits in adolescents with OCD. The study is led by Drs. James McCracken and A Moses Lee.
If you are interested, please visit our website and fill out our interest form.
TMS has been shown to be an effective form of treatment in individuals with Obsessive Compulsive Disorder (OCD). By using a form of TMS termed theta-burst stimulation (TBS), we hope that this will result in a more effective treatment by producing faster symptom reduction. Standard TMS involves an 18-minute treatment session daily for 5 consecutive days over the course of 6 weeks. We are trialing a novel form of accelerated TBS, where we will deliver ten 10-minute sessions per day, for up to 5 days.
This study will compare the efficacy of TMS for OCD at two distinct brain regions. Participants will be randomized into one of two study groups, and receive stimulation at either the DMPFC or R-OFC. Both regions have been linked to OCD by research. Participants who do not experience a reduction in OCD symptoms following study treatment to one brain region will have the option to receive treatment at the other.
We’re looking for participants who:
- Are 18-80 years of age
- Have a diagnosis/prominent symptoms of OCD
We reluctantly cannot accept any participants who:
- Have any brain lesions or other clinically significant abnormalities
- Are pregnant
- Have a history of epilepsy/seizure
For participant’s rights questions, contact 1-866-680-2906
For more information: https://bsl.stanford.edu/ocd-tms-stanford/
Stanford: Efficacy of Nitrous Oxide in OCD
Nitrous oxide (known as “laughing gas”) has a mechanism of action similar to that of ketamine. Like ketamine, it has been shown to rapidly improve symptoms of depression in clinical trials. Given the established safety profile of nitrous oxide, we are studying whether it may rapidly decrease symptoms of OCD. Eligible adults with OCD (ages 18‒65) who are not currently taking medications will be randomized to receive a 1-hour inhalation of 50% nitrous oxide or placebo, with EEG (brain wave) recording and monitoring of OCD symptoms for two weeks. Those who benefit may be eligible for a second phase of the study investigating how nitrous oxide brings about improvement.
Funding: Brain & Behavior Research Foundation
Enrolling: Ongoing, in-person
Please contact us about participating at:
https://med.stanford.edu/
650-723-4095
Maryland
Researchers at the Johns Hopkins School of Medicine are conducting a treatment research study to examine the feasibility, acceptability, and therapeutic benefit of personalized, ecological momentary assessment (EMA) of OCD for children and adolescents. Towards this goal, we will compare EMA-personalized cognitive behavior therapy (CBT) to standard CBT for youth with OCD. (IRB00406231; Principal Investigator: Joseph McGuire, PhD).
In order to participate, youth must:
- meet diagnostic criteria for OCD
- 8-17 years of age
- be fluent in English
If you are interested in participating, please reach out to us via email (coach@jhmi.edu) or phone (443-300-8836).
Researchers at the Johns Hopkins University are seeking individuals with Obsessive-Compulsive Disorder to participate in a research study looking at the effects of psilocybin, a psychoactive substance found in naturally occurring mushrooms. The study will investigate psychological effects of psilocybin, including whether or not it can help with Obsessive-Compulsive Disorder (OCD).
Volunteers must be between the ages of 21 and 70, have OCD, and have no recent history of drug abuse.
To discuss the possibility of volunteering or to learn more:
Phone: 410–550–5250 or
Email: OCDstudy@jhmi.edu
Website: https://hopkinspsychedelic.org/ocd-study
Confidentiality will be maintained for all applicants and participants.
Principal Investigator: David Yaden, Ph.D.
Protocol: IRB00284207
Massachusetts
Do you suffer from Obsessive-Compulsive Disorder (OCD)?
The Cognitive & Clinical Neuroscience Laboratory at Boston University seeks participants with OCD for several research studies and clinical trials.
Up to 12 in-person/virtual sessions.
Compensation: $20 per hour
Studies involve psychological interviews, neuroimaging (EEG/MRI), and noninvasive brain stimulation (transcranial electrical stimulation).
For more information, please call (617) 358-8110 or email at cogneuro@bu.edu
Minnesota
Neuromodulation + Exposure Therapy (NExT) Study
Do you have a child or know someone between 12-21 years old seeking treatment for OCD? They might be eligible for the NExT Study! This study uses a type of non-invasive brain stimulation called Transcranial Magnetic Stimulation (TMS). A different form of TMS has been approved for adults with OCD, but this is the first trial of TMS in youth with OCD. Participants will receive two weeks of daily treatment with TMS and Exposure plus Response Prevention (ERP) therapy. ERP is a highly effective standard treatment for OCD in youth and young adults.
WHO can join the NExT Study?
- Must be between 12-21 years old
- Must be right-handed
- Must be able to undergo an MRI scan
WHERE does the NExT Study take place?
This study is being conducted across two sites, the Pediatric Anxiety Research Center (PARC) at Bradley Hospital in East Providence, RI and the Minnesota Tic and Compulsivity (MnTiC) Lab at the University of Minnesota in Minneapolis, MN.
WHAT will study participants do in the NExT Study?
- Complete two weeks of TMS and ERP treatment for OCD
- Complete behavioral and clinical assessments throughout the course of the study
- Undergo MRI scanning before and after treatment
WHY should you participate in the NExT Study?
Participants will receive ERP, an evidence-based treatment for OCD. Participants will also be compensated for their time. Participation in this study can help us better understand how TMS can benefit kids with OCD and potentially lead to a new option for pediatric OCD treatment.
HOW can you participate in the NExT Study?
Call us at (612) 626-5550 or visit our website: https://ticlab.umn.edu/our-research/current-research/next
Missouri
Join our study! Light therapy for OCD
We are looking for participants with OCD who have late bedtimes and are ages 18-35.
The study is 7 weeks long with 8 in-person visits at Washington University in St. Louis.
Participants will complete 2 weeks of sleep and light exposure monitoring at home, in-lab light
sensitivity and melatonin assessments, and 5 weeks of at-home treatment with an in-person
check-in with staff after 1 week of treatment. Compensation is up to $1325.
The purpose of this study is to examine whether morning bright light improves symptoms of
obsessive-compulsive disorder (OCD) in young adults with OCD and late bedtimes.
For more details and information on how to apply, please visit the website in our bio
(https://sites.wustl.edu/scraplab/) or email us at scraplab@wustl.edu and ask about the Light
Therapy for OCD study.
New Jersey
New York
Columbia University: Cognitive training and CBT for children with OCD
This research study will examine how an iPad-based cognitive training game combined with cognitive behavioral therapy (CBT) helps children with excessive worries and related repetitive behaviors (“obsessive compulsive disorder”). Children ages 8-12 may be eligible to participate.
Who Can Participate?
- Age (years) is between 8 and 12
- Bothered by worries, fears, obsessions, or compulsions (rituals)
- Interference from worries or fears (e.g., school attendance or performance, relationships with family members or peers, involvement in activities)
- Note: No previous formal diagnosis required
What is Involved?
Eligible children will complete a clinical evaluation, questionnaires, 2 MRI scans, and cognitive training games at home on an iPad loaned to you.
Compensation
Your child can receive compensation up to $400 in the form of gift cards for participating in this study. After completing the study, all children will be offered CBT delivered by experts at no cost.
Click bit.ly/join-ocd-study to learn more.
Contact childocdstudy@cumc.columbia.edu or call 646-774-5868 for any questions.
Pennsylvania
Researchers at Penn State University are interested in learning more about the relationship among sleep patterns, thoughts, behaviors, and emotions in OCD. The findings from this research may help improve understanding of mechanisms that maintain obsessive-compulsive symptoms and improve interventions by targeting them in treatment. This project will offer you the opportunity to receive an Amazon e-giftcard of up to $50.00 as compensation.
This study has three parts:
- In the initial assessment visit, we will administer a videotaped in-person clinical interview and a brief questionnaire to determine if you are eligible to participate in our study. This will take approximately 20-30 minutes. If you are eligible and decide to continue in the study, there will be additional questionnaires (taking approximately 25 minutes) and a brief ½ hour training session where we will instruct you in the use of a mobile application for completing daily surveys and wearing a sleep watch. The initial visit will take place over Zoom.
- For the next 7 days, you will complete seven 4 minute questionnaires per day and monitor your sleep by wearing a sleep watch (that will be sent to you by mail) and maintaining a daily sleep diary.
- On day 4, there will be a brief compliance check Zoom visit where you will be informed about your overall compliance rate.
- At the end of the study, you will receive a pre-paid shipping label to return the sleep watch to us and will receive an Amazon e-giftcard as compensation based on your study compliance.
For more information, please contact Valerie Swisher at vss5199@psu.edu
Rhode Island
Neuromodulation + Exposure Therapy (NExT) Study
Do you have a child or know someone between 12-21 years old seeking treatment for OCD? They might be eligible for the NExT Study! This study uses a type of non-invasive brain stimulation called Transcranial Magnetic Stimulation (TMS). A different form of TMS has been approved for adults with OCD, but this is the first trial of TMS in youth with OCD. Participants will receive two weeks of daily treatment with TMS and Exposure plus Response Prevention (ERP) therapy. ERP is a highly effective standard treatment for OCD in youth and young adults.
WHO can join the NExT Study?
- Must be between 12-21 years old
- Must be right-handed
- Must be able to undergo an MRI scan
WHERE does the NExT Study take place?
This study is being conducted across two sites, the Pediatric Anxiety Research Center (PARC) at Bradley Hospital in East Providence, RI and the Minnesota Tic and Compulsivity (MnTiC) Lab at the University of Minnesota in Minneapolis, MN.
WHAT will study participants do in the NExT Study?
- Complete two weeks of TMS and ERP treatment for OCD
- Complete behavioral and clinical assessments throughout the course of the study
- Undergo MRI scanning before and after treatment
WHY should you participate in the NExT Study?
Participants will receive ERP, an evidence-based treatment for OCD. Participants will also be compensated for their time. Participation in this study can help us better understand how TMS can benefit kids with OCD and potentially lead to a new option for pediatric OCD treatment.
HOW can you participate in the NExT Study?
Call us at (401) 432-1662, or visit our website: https://www.parcanxiety.org/next-study
Texas
Join a free treatment study to address childhood anxiety/OCD!
Is your child between the ages of 7 and 13? Does your child experience symptoms of anxiety and/or OCD? Do you currently reside in Texas?
If so, you may be eligible to participate in a study delivering one of three family-oriented telehealth interventions for anxiety and OCD in children. This program is delivered over videoconferencing and email to your home. Participation involves a free 12-14-week course of therapy for children with anxiety and/or OCD and several assessments conducted via videoconferencing.
Participants will receive: Free therapy intervention for children with anxiety and/or OCD.
This study is being conducted by Eric Storch, Ph.D. at Baylor College of Medicine, Houston, TX. If you are interested or unsure if you meet the requirements, please contact the study coordinator at: COSMOSProgram@bcm.edu or call 832-206-4034. Or, fill out a brief survey to let us know that you are interested: https://redcap.research.bcm.edu/redcap/surveys/?s=NECME9TCWLL47ELC
United States
Researchers at the Johns Hopkins University are seeking individuals with Obsessive-Compulsive Disorder to participate in a research study looking at the effects of psilocybin, a psychoactive substance found in naturally occurring mushrooms. The study will investigate psychological effects of psilocybin, including whether or not it can help with Obsessive-Compulsive Disorder (OCD).
Volunteers must be between the ages of 21 and 70, have OCD, and have no recent history of drug abuse.
To discuss the possibility of volunteering or to learn more:
Phone: 410–550–5250 or
Email: OCDstudy@jhmi.edu
Website: https://hopkinspsychedelic.org/ocd-study
Confidentiality will be maintained for all applicants and participants.
Principal Investigator: David Yaden, Ph.D.
Protocol: IRB00284207
Canada
Obsessive-compulsive disorder (OCD) is a common mental health condition that affects millions of Canadians. OCD starts early in life, persists for a long time, and may increase the risk of developing other mental health conditions. To better understand the causes of OCD, it is important to further investigate the brain biology of OCD, and develop new and effective treatments.
For this study, we are looking for individuals aged 18 to 50 years old who currently experience obsessive-compulsive disorder. We will use brain imaging techniques, including PET (positron emission tomography) and MRI (magnetic resonance imaging) scans to observe and study whether an important brain network contributes to OCD. This will help us learn more about the biological mechanisms of this condition and also potentially guide development of new treatment options.
The study includes:
- A pre-screening phone call (approximately 25 minutes)
- A screening assessment visit (approximately 4 hours)
- One MRI scan visit (approximately 2 hours)
- One PET scan visit (approximately 4 hours)
- Assessments for memory, problem solving and other thinking abilities (approximately 1 hour)
- Take home questionnaires (approximately 6 hours)
You may be eligible if:
- aged 18 - 50 years old
- experience frequent unwanted thoughts or urges that keep coming back (obsessions) that might cause you to perform repetitive behaviors (compulsions) OR be diagnosed with OCD
- no current substance use disorders
- no blood clotting disorder or use of blood thinner medication
- no unstable medical condition
- no neurological illness (seizures, epilepsy) or head trauma
- no metal implants in body
- not pregnant / breastfeeding
- not claustrophobic
Participants will receive compensation for time, including transportation and meals.
For more information about this research study, please contact:
P: 416 535-8501 ext. 31609
Study Lead: Dr. Stefan Kloiber
The security of information sent by email cannot be guaranteed. Please do not communicate personal sensitive information by email. Emails are not monitored outside of work hours. Please do not use email to communicate emergency or urgent health matters – please contact your clinician or, in case of a medical emergency, call 911.For information about programs and services at CAMH, please visit www.camh.ca or call 416-535-8501 (or 1-800-463-6273).
We are recruiting people with Body Dysmorphic Disorder (BDD) or the symptoms of BDD for a study on visual perception in Toronto, Canada. The results from this study will help us understand how the brains of people with BDD, in combination with their behavior and their emotions, contribute to abnormal visual perceptual processing. Importantly, it will also help us understand if techniques to modify visual processing can change perception.
Participation in this study involves 3 study visits within 7-10 days (no more than 16 hours in total). The informed consent discussion and visit 1 will be done online via secure videoconferencing, while the rest of the study visits will require in-person visits at Toronto Health Network’s Toronto Western Hospital. Participation in the study involves the completion of clinical assessments and symptom rating scales, taking photographs of your face to be used in the study tasks, and undergoing a brain MRI scan and TMS stimulation. You will be compensated for your time should you wish to participate and complete all study visits.
Research Study Posting Policy
Requirements to post a research study recruitment advertisement on this webpage and/or in the OCD Newsletter.
- The Principal Investigator (PI), or someone involved in the research study who wishes to post it, must be a current IOCDF Professional or Student/Trainee Member.
- Email a copy of the most recent IRB study approval, including approval for advertising/recruitment, to research@iocdf.org. (Note: for a study to be posted in both places, the IRB approval must cover both online and printed material.)
- Once IRB approval is received and verified by the IOCDF, email the advertisement text to research@iocdf.org exactly as it is to appear and indicate whether it is to be posted online, in the newsletter, or both. (Note: listings have a max word count of 200; newsletter listings will be added to a queue on a first-come, first served basis.)
- Studies will be listed in one edition of the newsletter free of charge. After that, a fee of $50 per edition will be applied for repeat listings, if desired.
- In an effort to ensure that our website promotes active listings, studies will remain on the website for three years, after which they will need to be resubmitted for relisting.
- Once the above requirements have been satisfied, the IOCDF will optionally re-share one social media post about your study via our Facebook, Twitter, or Instagram account. For us to do this, please send a link to the post from your institution’s official social media account to research@iocdf.org.
Please contact us at (617) 973-5801 or research@iocdf.org with any questions or concerns.